Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Bacillus calmette-guerin tablet

A technology of BCG and BCG tablets, which is applied in the field of BCG tablets, can solve problems such as inconvenient treatment for patients, influence on popularization and application, induration, pain, etc., improve the ability of phagocytosis and anti-interferon, and improve rabbit immunity. Function, effect of improving catarrh symptoms

Inactive Publication Date: 2014-01-29
QINGDAO AGRI UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In recent years, scholars at home and abroad have discovered that BCG has many uses. After clinical application, it has a significant effect on preventing colds, asthma, chronic bronchitis, rheumatoid arthritis, and neurodermatitis. However, the current dosage forms are all injections. It must be treated by a hospital, which brings inconvenience to patients, especially in rural areas and children with poor medical conditions, which affects its popularization and application, and multiple intramuscular injections will also produce side effects such as induration and pain.
[0003] The purpose of the present invention is to provide a new dosage form of BCG, i.e. BCG tablet, so that it does not require injection, is convenient to take, is convenient to take along and overcomes the pain caused by injection, induration and inconvenience, etc., so that BCG This drug with multiple medical effects has been widely used

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0008] BCG hot phenol ethanol extract 2g, sugar 40g, starch 300g, stir evenly, press into 1000 tablets of 0.45g each.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a bacillus calmette-guerin tablet, comprising 0.5-0.8% of bacillus calmette-guerin bacteria, 15-20% of adhesive and 70-85% of disintegrating agent. An animal experiment and clinical application show that the tablet has the same clinical application range and effect as injection, and is convenient to take and carry; the defect that the injection generates a side effect is overcome.

Description

technical field [0001] The invention relates to a new dosage form of BCG, that is, BCG tablet. Background technique [0002] BCG is a well-known preventive and therapeutic agent for tuberculosis. In recent years, scholars at home and abroad have discovered that BCG has many uses. After clinical application, it has a significant effect on preventing colds, asthma, chronic bronchitis, rheumatoid arthritis, and neurodermatitis. However, the current dosage forms are all injections. It must be treated by a hospital, which brings inconvenience to patients, especially in rural areas and children with poor medical conditions, which affects its popularization and application, and multiple intramuscular injections will also produce side effects such as induration and pain. [0003] The purpose of the present invention is to provide a new dosage form of BCG, i.e. BCG tablet, so that it does not require injection, is convenient to take, is convenient to take along and overcomes the pai...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/20A61K39/04A61P31/06
Inventor 不公告发明人
Owner QINGDAO AGRI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com